La Manna et al. designed the SOCS3 peptidomimetic KIRESS which is able to interact with the Janus kinase (JAK)/STAT/gp130 complex and inhibit tumour growth and lung metastases in TNBC MDA-MB-231 xenografts [45]. The gene discussed is SOCS3; the disease is neoplasm.